[go: up one dir, main page]

GR3004333T3 - - Google Patents

Info

Publication number
GR3004333T3
GR3004333T3 GR920400692T GR920400692T GR3004333T3 GR 3004333 T3 GR3004333 T3 GR 3004333T3 GR 920400692 T GR920400692 T GR 920400692T GR 920400692 T GR920400692 T GR 920400692T GR 3004333 T3 GR3004333 T3 GR 3004333T3
Authority
GR
Greece
Prior art keywords
preanesthesia
halotane
antagonizes
carnitine
kidneys
Prior art date
Application number
GR920400692T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004333T3 publication Critical patent/GR3004333T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GR920400692T 1986-07-04 1992-04-13 GR3004333T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Publications (1)

Publication Number Publication Date
GR3004333T3 true GR3004333T3 (el) 1993-03-31

Family

ID=11265360

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400692T GR3004333T3 (el) 1986-07-04 1992-04-13

Country Status (7)

Country Link
US (1) US4780308A (el)
EP (1) EP0253777B1 (el)
AT (1) ATE73326T1 (el)
DE (1) DE3777270D1 (el)
ES (1) ES2033341T3 (el)
GR (1) GR3004333T3 (el)
IT (1) IT1195852B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
ATE73326T1 (de) 1992-03-15
IT1195852B (it) 1988-10-27
EP0253777B1 (en) 1992-03-11
DE3777270D1 (de) 1992-04-16
EP0253777A2 (en) 1988-01-20
US4780308A (en) 1988-10-25
ES2033341T3 (es) 1993-03-16
IT8648228A0 (it) 1986-07-04
IT8648228A1 (it) 1988-01-04
EP0253777A3 (en) 1990-01-31

Similar Documents

Publication Publication Date Title
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
CA2040248A1 (en) Method of inhibiting gastric acid secretion
AU3479889A (en) New antiviral drug
EP1484059A3 (en) Antiviral composition comprising phenylacetic acid derivatives
HU9201578D0 (en) A new peptide and method for producing it
ZA894508B (en) Pharmaceutical compounds
AU4466789A (en) Xanthine derivatives
NZ212768A (en) 2-substituted-1,3-propylidene diphosphonate derivatives and pharmaceutical compositions
EP0376899A3 (en) Use of L-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
GR3004333T3 (el)
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
ES468170A1 (es) Un procedimiento para la preparacion de un nuevo derivado demorfina
WO1990003172A3 (en) Bile acids for treatment of viral infections
ZA923437B (en) Preparation of organic salts or N-phosphonomethylglycine.
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
GR900300082T1 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
LTIP1735A (en) Use of bambuterol for the manufacture of a pharmaceutical preparation with lipid lowering effect
HK69890A (en) Pharmaceutical compositions containing reduced glutathione
JPS5473128A (en) Blood lipid depressing agent
RU97120428A (ru) Способ моделирования гипотиреоза
JPS543072A (en) Peptide derivatives
IT1247879B (it) 6,9-bis (amino sostituiti) benzo(g) ftalazin-5,10-dioni come farmaci antitumorali.
ES8302624A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxiacetico".